Pharmacological activation of wild-type p53 in the therapy of leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological activation of wild-type p53 in the therapy of leukemia

Published:2016-09 Issue:9 Volume:44 Page:791-798
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Kojima Kensuke,Ishizawa Jo,Andreeff Michael

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

Princess Takamatsu Cancer Research Fund

National Institutes of Health

Cancer Center Support

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference85 articles.

1. Translating p53 into the clinic;Cheok;Nat Rev Clin Oncol,2011

2. Regulation of the p53 response and its relationship to cancer;Meek;Biochem J,2015

3. Drugging the p53 pathway: understanding the route to clinical efficacy;Khoo;Nat Rev Drug Discov,2014

4. Unravelling mechanisms of p53-mediated tumour suppression;Bieging;Nat Rev Cancer,2014

5. Hitting cancers' weak spots: vulnerabilities imposed by p53 mutation;Gurpinar;Trends Cell Biol,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies;Cancer Medicine;2024-07

2. Discovery of novel co-degradation CK1α and CDK7/9 PROTACs with p53 activation for treating acute myeloid leukemia;Bioorganic Chemistry;2024-06

3. Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets;American Journal of Cancer Research;2024

4. An updated review of a novel method for examining P53 mutations in different forms of cancer;Pathology - Research and Practice;2023-08

5. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax;Journal of Experimental & Clinical Cancer Research;2023-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3